Table 3.
TLR2 gene polymorphism | Alleles | |||||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
Groups | CagA status | TT | CT | CC | Total | C | T | p |
PU | CagA+ | 27 (38.6%) | 34 (48.6%) | 9 (12.9%) | 70 (100.0%) | 52 (37.1%) | 88 (62.9%) | *0.22 |
CagA- | 7 (23.3%) | 16 (53.3%) | 7 (23.3%) | 30 (100.0%) | 30 (50.0%) | 30 (50.0%) | **0.09 | |
Total | 34 (34.0%) | 50 (50.0%) | 16 (16.0%) | 100 (100.0%) | 82 (41.0%) | 118 (59.0%) | ||
AS | CagA+ | 24 (31.6%) | 40 (52.6%) | 12 (15.8%) | 76 (100.0%) | 64 (42.1%) | 88 (57.9%) | *0.03 |
CagA- | 26 (52.6%) | 15 (30.6%) | 8 (16.3%) | 49 (100.0%) | 31 (31.6%) | 67 (68.4%) | **0.09 | |
Total | 50 (40.0%) | 55 (44.0%) | 20 (16.0%) | 125 (100.0%) | 95 (38.0%) | 155 (62.0%) | ||
NHS | ---- | 56 (44.8%) | 39 (31.2%) | 30 (24.0%) | 125 (100.0%) | 99 (39.6%) | 151 | (0.4%) |
comparison of the genotypes and alleles distribution at SNP rs4986790 between subjects infected with CagA+ strains of H. pylori and those infected with CagA- strains of bacteria in specified group
AS: asymptomatic subjects; CagA: cytotoxin-associated gene A; NHS: non-infected healthy subjects; PU: peptic ulcer; SNP: single nucleotide polymorphism; TLR: Toll-like receptors